Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sensex Trades Marginally Lower; Telecom & Healthcare Stocks Drag
Fri, 18 Jan 12:30 pm | Monish Vora, TM Team

Share markets in India are presently trading on a negative note. Barring energy sector, all sectoral indices are trading in red with stocks in the telecom sector, FMCG sector and healthcare sector witnessing maximum selling pressure.

The BSE Sensex is trading down by 81 points (down 0.2%), while the NSE Nifty is trading down by 26 points (down 0.2%). The BSE Mid Cap index is trading down by 0.4% and the BSE Small Cap index is trading down by 0.5%.

The rupee is trading at Rs 71.14 against the US$.

Market participants are tracking Wipro, NIIT Technologies, L&T Infotech, Dhanlaxmi Bank as they announce their December ended quarter results today.

In the latest development from the results corner, Hindustan Unilever share price has posted 9% growth in its net profit at Rs 14.4 billion as compared to Rs 13.3 billion in the same period last year.

Revenues came in at Rs 93.6 billion in Q3FY19, witnessing a growth of 12.4% against Rs 83.2 billion in Q3FY18.

To know more about the company you can read HUL Q3FY19 Result Analysis and HUL Annual Report Analysis on our website.

You can also read our recently released Q3FY19 results: Zee Entertainment's latest result analysis, Reliance Industries, Federal Bank, Infosys, TCS, Trident.

In the news from the commodity space, oil prices edged higher today after a report from the Organization of the Petroleum Exporting Countries (OPEC) showed its production fell sharply last month, easing fears about prolonged oversupply.

--- Advertisement ---
India is Set to Regain Its Lost Riches

REBIRTH OF INDIA India was the world's richest country nearly 2,000 years ago. In fact, we were referred to as the "Sone Ki Chidiya."

If you are like us who believe that India has the potential to be once again the "Sone Ki Chidiya" to the world again…and regain its status as one among the greatest countries on earth…

Then, I encourage you to join other true Indians in the first-ever mega summit "REBIRTH OF INDIA" for FREE.


Don't Miss it!

Click Here to Claim Your FREE Pass for this MEGA Summit…

Looking at oil supplies, 2019 crude prices have been supported by supply cuts from a group of producers around the Middle East-dominated Organization of the Petroleum Exporting Countries (OPEC) as well as non-OPEC member Russia.

OPEC oil supply fell by 460,000 barrels per day (bpd) between November and December, to 32.7 million bpd, as top exporter Saudi Arabia made an early start to a supply-limiting accord, while Iran and Libya posted involuntary declines.

It would be interesting to see how this pans out. Meanwhile, we will keep you updated on all the developments from this space.

Moving on to the news from the pharma space, Sun Pharma share price is witnessing selling pressure today on reports that new whistleblower documents had been sent to the markets regulator.

According to a news report by a financial news website, huge transactions of over Rs 58 billion allegedly took place between Aditya Medisales and private companies of Sun Pharma's promoters between 2014 and 2017.

This is as per a new 172-page complaint (with documents) sent by the whistleblower on Sun Pharma to the markets regulator.

Shares of the company fell as much as 12% today on back of the above news.

Last month, a note by Macquarie, an Australian brokerage firm went viral which raised concerns among the investing community.

The note raised questions about inadequate disclosures regarding the role of promoter Dilip Shanghvi's brother-in-law Sudhir Valia, Sun Pharma's past links with banned traders Ketan Parekh and Dharmesh Doshi, related party transactions involving promoter Shanghvi and guarantees given to real estate firm Suraksha Realty.

In November, a whistleblower had approached markets regulator with a document alleging various irregularities by the company, its promoter Shanghvi and others.

The whistleblower made allegations in a 150-page letter sent to the markets regulator, which had earlier banned Doshi and Parekh following the 2001 scam.

According to the news in a leading financial daily, the irregularities involved two or three major rounds of foreign currency convertible bonds (FCCBs) issues by Sun Pharma during 2002-2007, which was managed by Jermyn Capital LLC.

The markets regulator reportedly is planning to reopen the investigation into the insider trading case against the company and its promoters which was settled through consent mechanism.

Speaking of pharma sector, note that the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

And since then it has been a painful ride downwards, as can be seen from the chart below:

The Roller Coaster Ride of the BSE Healthcare Index

As we wrote in one of our editions of The 5 Minute WrapUp...

  • Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

    The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

    No wonder, the US regulatory authority (USFDA) took strict action. Sun Pharma received a warning letter for its Halol manufacturing facility in 2015. It was like a bolt out of the blue. Since then, the downward spiral began and has continued till date.

We believe that pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market as well as in the overall industry.

To know more on what moved the Indian stock markets today, you can check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Trades Marginally Lower; Telecom & Healthcare Stocks Drag". Click here!


Stock Market Updates

RELIANCE COMMUNICATIONS Surges by 11%; BSE 500 Index Up 0.0% (Today's Market)

Feb 22, 2019 09:44 AM

RELIANCE COMMUNICATIONS share price has surged by 11% and its current market price is Rs 7. The BSE 500 is up by 0.0%. The top gainers in the BSE 500 Index are RELIANCE COMMUNICATIONS (up 10.6%) and RELIANCE NIPPON LIFE ASSET MANAGEMENT LTD (up 10.0%). The top losers are CENTURY TEXTILES and AJANTA PHARMA .

SUZLON ENERGY Surges by 6%; BSE OIL & GAS Index Up 0.6% (Today's Market)

Feb 22, 2019 09:34 AM

SUZLON ENERGY share price has surged by 6% and its current market price is Rs 5. The BSE OIL & GAS is up by 0.6%. The top gainers in the BSE OIL & GAS Index is SUZLON ENERGY (up 5.9%). The top losers are GAIL (down 0.5%) and RELIANCE IND. (down 0.6%).

DISH TV Plunges by 5%; BSE 500 Index Up 0.0% (Today's Market)

Feb 22, 2019 09:34 AM

DISH TV share price has plunged by 5% and its current market price is Rs 37. The BSE 500 is up by 0.0%. The top gainers in the BSE 500 Index are SUZLON ENERGY (up 5.9%) and JAIPRAKASH ASSO. (up 5.4%). The top losers is DISH TV (down 5.3%)..

BATA INDIA at All Time High; BSE FMCG Index Up 0.1% (Today's Market)

Feb 22, 2019 09:34 AM

BATA INDIA share price has hit an all time high at Rs 1,300 (up 0.9%). The BSE FMCG Index is up by 0.1%. Among the top gainers in the BSE FMCG Index today are BATA INDIA (up 0.9%) and NESTLE (up 0.3%). The top losers include ITC LTD (down 0.2%) and COLGATE (down 0.2%).

JAIPRAKASH ASSO. Surges by 5%; BSE REALTY Index Up 0.7% (Today's Market)

Feb 22, 2019 09:32 AM

JAIPRAKASH ASSO. share price has surged by 5% and its current market price is Rs 6. The BSE REALTY is up by 0.7%. The top gainers in the BSE REALTY Index is JAIPRAKASH ASSO. (up 5.1%). The top losers is PHOENIX MILL (down 1.5%).

View More Indian Share Market News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Feb 22, 2019 09:45 AM